Yoshida et al., 2000 - Google Patents
Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contactYoshida et al., 2000
View HTML- Document ID
- 12325872574790223701
- Author
- Yoshida M
- Takeuchi M
- Streilein W
- Publication year
- Publication venue
- Investigative ophthalmology & visual science
External Links
Snippet
purpose. To determine by what mechanism (s) iris and ciliary body (I/CB) pigment epithelial (PE) cells inhibit T-cell activation in vitro. methods. Pure cultured I/CB PE cells were obtained from eyes of normal and CD95 ligand (CD95L)-deficient mice and tested for their …
- 210000004240 Ciliary Body 0 title abstract description 23
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yoshida et al. | Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact | |
| Ohta et al. | IL-6 antagonizes TGF-β and abolishes immune privilege in eyes with endotoxin-induced uveitis | |
| Kuwana et al. | Induction of antigen‐specific human CD4+ T cell anergy by peripheral blood DC2 precursors | |
| Castro-Sánchez et al. | Gut immune system and oral tolerance | |
| Nishida et al. | Specific aqueous humor factors induce activation of regulatory T cells | |
| Wolf et al. | Neuroprotection by T-cells depends on their subtype and activation state | |
| Kitaichi et al. | Inducible immune regulation following autoimmune disease in the immune-privileged eye | |
| US20020090724A1 (en) | Activation of regulatory T cells by alpha-melanocyte stimulating hormone | |
| Ohta et al. | Effects of experimental ocular inflammation on ocular immune privilege | |
| Yoshida et al. | Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-β–producing regulatory T cells | |
| Kezuka et al. | In Vitro Generation of Regulatory CD8+ T Cells Similar to those Found in Mice with Anterior Chamber–Associated Immune Deviation | |
| Mo et al. | Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS | |
| Imai et al. | Immunosuppressive properties of regulatory T cells generated by incubation of peripheral blood mononuclear cells with supernatants of human RPE cells | |
| Kitaichi et al. | Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells | |
| Johnson et al. | Minireview The role of anergy in peripheral T cell unresponsiveness | |
| Sonoda et al. | Ocular immune privilege and CD1d-reactive natural killer T cells | |
| Martins et al. | CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection | |
| Rezai et al. | Human fetal retinal pigment epithelial cells induce apoptosis in allogenic T-cells in a Fas ligand and PGE2 independent pathway | |
| Galbiati et al. | Regulation of the IL‐12 receptor β2 subunit by soluble antigen and IL‐12 in vivo | |
| Kosiewicz et al. | Tolerogenic antigen-presenting cells: regulation of the immune response by TGF-β-treated antigen-presenting cells | |
| Yamada et al. | Promotion of corneal allograft survival by the induction of oxidative macrophages | |
| Takeuchi et al. | Anterior chamber‐associated immune deviation‐inducing cells activate T cells, and rescue them from antigen‐induced apoptosis | |
| EP1100515B1 (en) | EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS | |
| Tan et al. | Biological characteristics of an immunoregulatory activity secreted by an autoreactive CD4+ T cell clone that suppresses autoimmune diabetes in non-obese diabetic mice | |
| AU2003261499B2 (en) | Ex vivo treatment of allogeneic and xenogeneic T-cells with gp39 antagonists |